Efflux inhibition with verapamil potentiates bedaquiline in mycobacterium tuberculosis

159Citations
Citations of this article
218Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Drug efflux is an important resistance mechanism in Mycobacterium tuberculosis. We found that verapamil, an efflux inhibitor, profoundly decreases the MIC of bedaquiline and clofazimine to M. tuberculosis by 8- to 16-fold. This exquisite susceptibility was noted among drug-susceptible and drug-resistant clinical isolates. Thus, efflux inhibition is an important sensitizer of bedaquiline and clofazimine, and efflux may emerge as a resistance mechanism to these drugs. © 2014, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Gupta, S., Cohen, K. A., Winglee, K., Maiga, M., Diarra, B., & Bishai, W. R. (2014). Efflux inhibition with verapamil potentiates bedaquiline in mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 58(1), 574–576. https://doi.org/10.1128/AAC.01462-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free